Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context

Summary: Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, driven primarily by coronary artery disease (CAD). ASCVD risk estimators such as the pooled cohort equations (PCE) facilitate risk stratification and primary prevention of ASCVD but their ac...

Full description

Bibliographic Details
Main Authors: Samir Awasthi, Nikhil Sachdeva, Yash Gupta, Ausath G. Anto, Shahir Asfahan, Ruben Abbou, Sairam Bade, Sanyam Sood, Lars Hegstrom, Nirupama Vellanki, Heather M. Alger, Melwin Babu, Jose R. Medina-Inojosa, Robert B. McCully, Amir Lerman, Mark Stampehl, Rakesh Barve, Zachi I. Attia, Paul A. Friedman, Venky Soundararajan, Francisco Lopez-Jimenez
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023004364
_version_ 1827631719072661504
author Samir Awasthi
Nikhil Sachdeva
Yash Gupta
Ausath G. Anto
Shahir Asfahan
Ruben Abbou
Sairam Bade
Sanyam Sood
Lars Hegstrom
Nirupama Vellanki
Heather M. Alger
Melwin Babu
Jose R. Medina-Inojosa
Robert B. McCully
Amir Lerman
Mark Stampehl
Rakesh Barve
Zachi I. Attia
Paul A. Friedman
Venky Soundararajan
Francisco Lopez-Jimenez
author_facet Samir Awasthi
Nikhil Sachdeva
Yash Gupta
Ausath G. Anto
Shahir Asfahan
Ruben Abbou
Sairam Bade
Sanyam Sood
Lars Hegstrom
Nirupama Vellanki
Heather M. Alger
Melwin Babu
Jose R. Medina-Inojosa
Robert B. McCully
Amir Lerman
Mark Stampehl
Rakesh Barve
Zachi I. Attia
Paul A. Friedman
Venky Soundararajan
Francisco Lopez-Jimenez
author_sort Samir Awasthi
collection DOAJ
description Summary: Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, driven primarily by coronary artery disease (CAD). ASCVD risk estimators such as the pooled cohort equations (PCE) facilitate risk stratification and primary prevention of ASCVD but their accuracy is still suboptimal. Methods: Using deep electronic health record data from 7,116,209 patients seen at 70+ hospitals and clinics across 5 states in the USA, we developed an artificial intelligence-based electrocardiogram analysis tool (ECG-AI) to detect CAD and assessed the additive value of ECG-AI-based ASCVD risk stratification to the PCE. We created independent ECG-AI models using separate neural networks including subjects without known history of ASCVD, to identify coronary artery calcium (CAC) score ≥300 Agatston units by computed tomography, obstructive CAD by angiography or procedural intervention, and regional left ventricular akinesis in ≥1 segment by echocardiogram, as a reflection of possible prior myocardial infarction (MI). These were used to assess the utility of ECG-AI-based ASCVD risk stratification in a retrospective observational study consisting of patients with PCE scores and no prior ASCVD. The study period covered all available digitized EHR data, with the first available ECG in 1987 and the last in February 2023. Findings: ECG-AI for identifying CAC ≥300, obstructive CAD, and regional akinesis achieved area under the receiver operating characteristic (AUROC) values of 0.88, 0.85, and 0.94, respectively. An ensembled ECG-AI identified 3, 5, and 10-year risk for acute coronary events and mortality independently and additively to PCE. Hazard ratios for acute coronary events over 3-years in patients without ASCVD that tested positive on 1, 2, or 3 versus 0 disease-specific ECG-AI models at cohort entry were 2.41 (2.14–2.71), 4.23 (3.74–4.78), and 11.75 (10.2–13.52), respectively. Similar stratification was observed in cohorts stratified by PCE or age. Interpretation: ECG-AI has potential to address unmet need for accessible risk stratification in patients in whom PCE under, over, or insufficiently estimates ASCVD risk, and in whom risk assessment over time periods shorter than 10 years is desired. Funding: Anumana.
first_indexed 2024-03-09T14:25:58Z
format Article
id doaj.art-97d6bc637a9f484f91ae2a92cbf0ea4a
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-03-09T14:25:58Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-97d6bc637a9f484f91ae2a92cbf0ea4a2023-11-28T07:26:43ZengElsevierEClinicalMedicine2589-53702023-11-0165102259Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in contextSamir Awasthi0Nikhil Sachdeva1Yash Gupta2Ausath G. Anto3Shahir Asfahan4Ruben Abbou5Sairam Bade6Sanyam Sood7Lars Hegstrom8Nirupama Vellanki9Heather M. Alger10Melwin Babu11Jose R. Medina-Inojosa12Robert B. McCully13Amir Lerman14Mark Stampehl15Rakesh Barve16Zachi I. Attia17Paul A. Friedman18Venky Soundararajan19Francisco Lopez-Jimenez20Anumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAnference, Inc, One Main Street, Cambridge, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Rochester, MN, USANovartis Pharmaceuticals Corporation, East Hanover, NJ, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAMayo Clinic, Rochester, MN, USAMayo Clinic, Rochester, MN, USAAnumana, Inc, One Main Street, Cambridge, MA, USA; nference, Inc, One Main Street, Cambridge, MA, USAMayo Clinic, Rochester, MN, USA; Corresponding author.Summary: Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, driven primarily by coronary artery disease (CAD). ASCVD risk estimators such as the pooled cohort equations (PCE) facilitate risk stratification and primary prevention of ASCVD but their accuracy is still suboptimal. Methods: Using deep electronic health record data from 7,116,209 patients seen at 70+ hospitals and clinics across 5 states in the USA, we developed an artificial intelligence-based electrocardiogram analysis tool (ECG-AI) to detect CAD and assessed the additive value of ECG-AI-based ASCVD risk stratification to the PCE. We created independent ECG-AI models using separate neural networks including subjects without known history of ASCVD, to identify coronary artery calcium (CAC) score ≥300 Agatston units by computed tomography, obstructive CAD by angiography or procedural intervention, and regional left ventricular akinesis in ≥1 segment by echocardiogram, as a reflection of possible prior myocardial infarction (MI). These were used to assess the utility of ECG-AI-based ASCVD risk stratification in a retrospective observational study consisting of patients with PCE scores and no prior ASCVD. The study period covered all available digitized EHR data, with the first available ECG in 1987 and the last in February 2023. Findings: ECG-AI for identifying CAC ≥300, obstructive CAD, and regional akinesis achieved area under the receiver operating characteristic (AUROC) values of 0.88, 0.85, and 0.94, respectively. An ensembled ECG-AI identified 3, 5, and 10-year risk for acute coronary events and mortality independently and additively to PCE. Hazard ratios for acute coronary events over 3-years in patients without ASCVD that tested positive on 1, 2, or 3 versus 0 disease-specific ECG-AI models at cohort entry were 2.41 (2.14–2.71), 4.23 (3.74–4.78), and 11.75 (10.2–13.52), respectively. Similar stratification was observed in cohorts stratified by PCE or age. Interpretation: ECG-AI has potential to address unmet need for accessible risk stratification in patients in whom PCE under, over, or insufficiently estimates ASCVD risk, and in whom risk assessment over time periods shorter than 10 years is desired. Funding: Anumana.http://www.sciencedirect.com/science/article/pii/S2589537023004364Artificial intelligenceECG-AICoronary artery diseaseAtherosclerotic cardiovascular diseaseCardiovascular risk
spellingShingle Samir Awasthi
Nikhil Sachdeva
Yash Gupta
Ausath G. Anto
Shahir Asfahan
Ruben Abbou
Sairam Bade
Sanyam Sood
Lars Hegstrom
Nirupama Vellanki
Heather M. Alger
Melwin Babu
Jose R. Medina-Inojosa
Robert B. McCully
Amir Lerman
Mark Stampehl
Rakesh Barve
Zachi I. Attia
Paul A. Friedman
Venky Soundararajan
Francisco Lopez-Jimenez
Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
EClinicalMedicine
Artificial intelligence
ECG-AI
Coronary artery disease
Atherosclerotic cardiovascular disease
Cardiovascular risk
title Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
title_full Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
title_fullStr Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
title_full_unstemmed Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
title_short Identification and risk stratification of coronary disease by artificial intelligence-enabled ECGResearch in context
title_sort identification and risk stratification of coronary disease by artificial intelligence enabled ecgresearch in context
topic Artificial intelligence
ECG-AI
Coronary artery disease
Atherosclerotic cardiovascular disease
Cardiovascular risk
url http://www.sciencedirect.com/science/article/pii/S2589537023004364
work_keys_str_mv AT samirawasthi identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT nikhilsachdeva identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT yashgupta identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT ausathganto identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT shahirasfahan identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT rubenabbou identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT sairambade identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT sanyamsood identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT larshegstrom identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT nirupamavellanki identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT heathermalger identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT melwinbabu identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT josermedinainojosa identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT robertbmccully identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT amirlerman identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT markstampehl identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT rakeshbarve identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT zachiiattia identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT paulafriedman identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT venkysoundararajan identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext
AT franciscolopezjimenez identificationandriskstratificationofcoronarydiseasebyartificialintelligenceenabledecgresearchincontext